BASF Launches New Good Manufacturing Practice Solution Center in USA

Business Expansion BASF Launches New Good Manufacturing Practice Solution Center in USA

2025-06-18 Source: Press release BASF 2 min Reading Time

Related Vendors

BASF SE

Turck_Your_Global_Automation_Partner.jpg ()

TURCK GmbH

Italvacuum, Srl

ProMinent GmbH

With an aim to provide innovative solutions in the biopharma and pharmaceutical ingredients industries, BASF has launched a new Good Manufacturing Practice Solution Center, in Wyandotte, Michigan, USA.

Pictured from left to right: Michele Barney (Wyandotte Site Director), Marion Kuhn (Vice President of Business Management, Pharma Solutions), Michael Murphy (Operations Product Manager, Pharma Solutions), Robert A. DeSana (Mayor of Wyandotte, Michigan), Joel Young (RG/PN Research Engineering Services Manager), Benjamin Knudsen (Vice President of Research North America), and Artem Gurvich (Head of Business Management, Biopharma).(Source: BASF Corporation) — Pictured from left to right: Michele Barney (Wyandotte Site Director), Marion Kuhn (Vice President of Business Management, Pharma Solutions), Michael Murphy (Operations Product Manager, Pharma Solutions), Robert A. DeSana (Mayor of Wyandotte, Michigan), Joel Young (RG/PN Research Engineering Services Manager), Benjamin Knudsen (Vice President of Research North America), and Artem Gurvich (Head of Business Management, Biopharma).
(Source: BASF Corporation)

New Jersey/USA – BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.

This new facility will play a crucial role in the expansion of BASF’s existing network of GMP sites, with innovative systems and processes that ensure products are produced consistently and controlled according to high quality standards. These practices are crucial in the pharmaceutical industry, where the quality of products is paramount for safety and efficacy.

Featuring state-of-the-art clean room packaging, and high-sensitivity analytical testing, this new facility enables close collaboration with customers on customized chemistries for product development. Additionally, improved manufacturing capabilities will allow for more tightly controlled parameters beyond compendial limits and a validated control system that allows for high reproductivity.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

Marion Kuhn, vice president of business management, BASF Pharma Solutions states, “Our new GMP Solution Center exemplifies BASF’s dedication to understanding and addressing the evolving needs of our customers in both the biopharma and pharmaceutical industries. This state-of-the-art facility will play a fundamental role in enabling us to collaborate closely with our customers worldwide on product development and GMP manufacturing in ways that are unique to the industry, further strengthening our position as an innovator in the pharmaceutical sector.”

“Wyandotte's new GMP Solution Center is a key example of BASF's commitment to innovative excellence,” said Benjamin Knudsen, vice president of research North America at BASF Corporation. “This expansion not only showcases our dedication to developing customized solutions, but it also highlights our ability to adapt and innovate in response to our customers’ needs. Together, we are paving the way for new innovative solutions.”

(ID:50456917)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.